189 related articles for article (PubMed ID: 35950629)
1. Semi-Synthetic Glycoconjugate Vaccine Lead Against Acinetobacter baumannii 17978.
Sianturi J; Priegue P; Hu J; Yin J; Seeberger PH
Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202209556. PubMed ID: 35950629
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Oligosaccharide Antigens for Semi-Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14*.
Zhang S; Sella M; Sianturi J; Priegue P; Shen D; Seeberger PH
Angew Chem Int Ed Engl; 2021 Jun; 60(26):14679-14692. PubMed ID: 33852172
[TBL] [Abstract][Full Text] [Related]
3. Immune Response to Conjugates of Fragments of the Type K9 Capsular Polysaccharide of Acinetobacter baumannii with Carrier Proteins.
Rudenko N; Karatovskaya A; Zamyatina A; Shepelyakovskaya A; Semushina S; Brovko F; Shpirt A; Torgov V; Kolotyrkina N; Zinin A; Kasimova A; Perepelov A; Shneider M; Knirel Y
Microbiol Spectr; 2022 Oct; 10(5):e0167422. PubMed ID: 35980044
[TBL] [Abstract][Full Text] [Related]
4. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant
Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C
Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799
[TBL] [Abstract][Full Text] [Related]
5. Protective Capacity of Monoclonal Antibodies against Acinetobacter baumannii K9 Capsular Polysaccharide.
Karatovskaya A; Rudenko N; Zamyatina A; Zvonarev A; Oleinikov V; Shpirt A; Perepelov A; Knirel Y; Brovko F
Microbiol Spectr; 2023 Feb; 11(1):e0414122. PubMed ID: 36622150
[TBL] [Abstract][Full Text] [Related]
6. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii.
Ahmad S; Azam SS
J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164
[TBL] [Abstract][Full Text] [Related]
7. Total Syntheses of Conjugation-Ready Repeating Units of Acinetobacter baumannii AB5075 for Glycoconjugate Vaccine Development.
Zhang S; Seeberger PH
Chemistry; 2021 Dec; 27(69):17444-17451. PubMed ID: 34665908
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
Nielsen TB; Pantapalangkoor P; Luna BM; Bruhn KW; Yan J; Dekitani K; Hsieh S; Yeshoua B; Pascual B; Vinogradov E; Hujer KM; Domitrovic TN; Bonomo RA; Russo TA; Lesczcyniecka M; Schneider T; Spellberg B
J Infect Dis; 2017 Aug; 216(4):489-501. PubMed ID: 28931235
[TBL] [Abstract][Full Text] [Related]
9. A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate.
Yang FL; Lou TC; Kuo SC; Wu WL; Chern J; Lee YT; Chen ST; Zou W; Lin NT; Wu SH
Vaccine; 2017 Mar; 35(10):1440-1447. PubMed ID: 28190743
[TBL] [Abstract][Full Text] [Related]
10. Pseudaminic Acid on Exopolysaccharide of Acinetobacter baumannii Plays a Critical Role in Phage-Assisted Preparation of Glycoconjugate Vaccine with High Antigenicity.
Lee IM; Yang FL; Chen TL; Liao KS; Ren CT; Lin NT; Chang YP; Wu CY; Wu SH
J Am Chem Soc; 2018 Jul; 140(28):8639-8643. PubMed ID: 29965749
[TBL] [Abstract][Full Text] [Related]
11. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
12. An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.
Shu MH; MatRahim N; NorAmdan N; Pang SP; Hashim SH; Phoon WH; AbuBakar S
Sci Rep; 2016 Feb; 6():22332. PubMed ID: 26923424
[TBL] [Abstract][Full Text] [Related]
13. Biology of
Lee CR; Lee JH; Park M; Park KS; Bae IK; Kim YB; Cha CJ; Jeong BC; Lee SH
Front Cell Infect Microbiol; 2017; 7():55. PubMed ID: 28348979
[No Abstract] [Full Text] [Related]
14. A semisynthetic
Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
[TBL] [Abstract][Full Text] [Related]
15. Antigen Epitope Developed Based on
Song X; Zhao G; Ding M
Biomed Res Int; 2020; 2020():1975875. PubMed ID: 33134372
[No Abstract] [Full Text] [Related]
16. Where are we and how far is there to go in the development of an
Ma C; Chen W
Expert Rev Vaccines; 2021 Mar; 20(3):281-295. PubMed ID: 33554671
[TBL] [Abstract][Full Text] [Related]
17. The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies.
Law SKK; Tan HS
Microbiol Res; 2022 Jul; 260():127032. PubMed ID: 35483311
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.
Ni Z; Chen Y; Ong E; He Y
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230771
[TBL] [Abstract][Full Text] [Related]
19. K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis.
Oliveira H; Mendes A; Fraga AG; Ferreira A; Pimenta AI; Mil-Homens D; Fialho AM; Pedrosa J; Azeredo J
Appl Environ Microbiol; 2019 Sep; 85(17):. PubMed ID: 31227554
[No Abstract] [Full Text] [Related]
20. Inhibition of Virulence Factors and Biofilm Formation of Acinetobacter Baumannii by Naturally-derived and Synthetic Drugs.
Bamunuarachchi NI; Khan F; Kim YM
Curr Drug Targets; 2021; 22(7):734-759. PubMed ID: 33100201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
